Ruth Oliver

Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation

Sophie Glatt, Dominique Baeten, Terry Baker et al. · Annals of the Rheumatic Diseases · 2017 · 259 citations · Full text

Medicine, Immunology, Pharmacology +17

Bimekizumab, a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F

Ralph Adams, Asher Maroof, Terry Baker et al. · Frontiers in Immunology · 2020 · 193 citations · Full text

Life Sciences, Immunology, Pathobiology +17

Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects

Ruth Dixon, Sarah A. Job, Ruth Oliver et al. · British Journal of Clinical Pharmacology · 2008 · 112 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Diagnostic classification of arterial spin labeling and structural MRI in presenile early stage dementia

Esther E. Bron, Rebecca M. E. Steketee, Ruth Oliver et al. · Human Brain Mapping · 2014 · 95 citations · Full text

Medicine, Neurology, Neuroscience +17

First-in-human trial of the safety, pharmacokinetics and immunogenicity of a PEGylated anti-CD40L antibody fragment (CDP7657) in healthy individuals and patients with systemic lupus erythematosus

Adina Tocoian, Peter Buchan, Hishani Kirby et al. · Lupus · 2015 · 74 citations

Pharmacy, Pharmacokinetics, Pharmacology +17